• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Albumin Administration in Critically Ill Patients

Audience: Critical care healthcare professionals
The FDA notified healthcare professionals of an update and revision to a 1998 notice with advice regarding the safety of albumin administration in critically ill patients. This action has been taken following FDA’s review of recent studies on the safety of albumin, and is consistent with recommendations made on March 17, 2005 by members of the Blood Products Advisory Committee (BPAC).
 

[May 16, 2005 - Notice - FDA]